Singh S, Verma M, Yadav A, Mishra A, Katiyar H, Dhiman R
Indian J Gastroenterol. 2025; .
PMID: 39962017
DOI: 10.1007/s12664-025-01748-w.
Hobart C, Pescarini J, Evans L, Adil H, Adil S, Deal A
J Travel Med. 2024; 31(6.
PMID: 38990201
PMC: 11298050.
DOI: 10.1093/jtm/taae094.
Chhavi N, Srivastava G, Waseem M, Yadav A, Singh S, Singh R
World J Virol. 2024; 13(2):92115.
PMID: 38984086
PMC: 11229838.
DOI: 10.5501/wjv.v13.i2.92115.
Agboeze J, Igwe N, Ukaegbe C
Niger Med J. 2024; 64(4):582-590.
PMID: 38952881
PMC: 11214719.
DOI: 10.60787/NMJ-64-4-347.
Tu T, Wettengel J, Xia Y, Testoni B, Littlejohn M, Bert N
Virology. 2024; 595:110089.
PMID: 38640789
PMC: 11517827.
DOI: 10.1016/j.virol.2024.110089.
Hepatitis B in Trans-Himalayan Tribal Population: High Prevalence, High Pediatric Burden, Virologic Patterns, and Implications for Public Health Interventions.
Sharma B, Bodh V, Sharma N, Sharma R, Sachdeva A, Gupta A
J Clin Exp Hepatol. 2024; 14(3):101336.
PMID: 38283704
PMC: 10809090.
DOI: 10.1016/j.jceh.2023.101336.
Vaccination Campaign against Hepatitis B Virus in Italy: A History of Successful Achievements.
Stroffolini T, Stroffolini G
Vaccines (Basel). 2023; 11(10).
PMID: 37896935
PMC: 10610604.
DOI: 10.3390/vaccines11101531.
Mathematical model analysis of effective intervention strategies on transmission dynamics of hepatitis B virus.
Wodajo F, Gebru D, Alemneh H
Sci Rep. 2023; 13(1):8737.
PMID: 37253760
PMC: 10227825.
DOI: 10.1038/s41598-023-35815-z.
A time-series analysis of morbidity and mortality of viral hepatitis in Venezuela, 1990-2016.
Risquez A, Echezuria L, Carrion-Nessi F, Forero-Pena D
BMC Infect Dis. 2023; 23(1):361.
PMID: 37245003
PMC: 10225089.
DOI: 10.1186/s12879-023-08338-1.
Estimated impact of the national hepatitis B immunization program on acute viral hepatitis B among adolescents in Republic of Korea.
Chae C, Tak S
Osong Public Health Res Perspect. 2023; 14(2):138-145.
PMID: 37183334
PMC: 10211452.
DOI: 10.24171/j.phrp.2022.0321.
Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations - United States, 2023.
Conners E, Panagiotakopoulos L, Hofmeister M, Spradling P, Hagan L, Harris A
MMWR Recomm Rep. 2023; 72(1):1-25.
PMID: 36893044
PMC: 9997714.
DOI: 10.15585/mmwr.rr7201a1.
Machine Learning Approaches for the Prediction of Hepatitis B and C Seropositivity.
Harabor V, Mogos R, Nechita A, Adam A, Adam G, Melinte-Popescu A
Int J Environ Res Public Health. 2023; 20(3).
PMID: 36767747
PMC: 9915359.
DOI: 10.3390/ijerph20032380.
Current Challenges and Future Perspectives of Diagnosis of Hepatitis B Virus.
Kumar M, Pahuja S, Khare P, Kumar A
Diagnostics (Basel). 2023; 13(3).
PMID: 36766473
PMC: 9914745.
DOI: 10.3390/diagnostics13030368.
Changing incidence of hepatitis B and persistent infection risk in adults: a population-based follow-up study from 2011 in China.
Xu X, Wu C, Lou Z, Peng C, Jiang L, Wu T
BMC Public Health. 2023; 23(1):256.
PMID: 36747172
PMC: 9901124.
DOI: 10.1186/s12889-023-15130-y.
How to Effectively Monitor Aging Patients with Chronic Hepatitis B: A Review.
Kang C, Brennan P, Dillon J
Clin Interv Aging. 2022; 17:1811-1820.
PMID: 36532948
PMC: 9748119.
DOI: 10.2147/CIA.S366255.
Studying Hepatitis Virus-Host Interactions in Patient Liver Biopsies.
Suslov A, Heim M, Wieland S
Viruses. 2022; 14(11).
PMID: 36366588
PMC: 9699472.
DOI: 10.3390/v14112490.
Epidemiological and clinical aspects of hepatitis B virus infection in Italy over the last 50 years.
Sagnelli C, Sica A, Creta M, Calogero A, Ciccozzi M, Sagnelli E
World J Gastroenterol. 2022; 28(26):3081-3091.
PMID: 36051347
PMC: 9331523.
DOI: 10.3748/wjg.v28.i26.3081.
Prevalence and molecular characterization of occult hepatitis B virus in pregnant women from Gondar, Ethiopia.
Meier-Stephenson V, Deressa T, Genetu M, Damtie D, Braun S, Fonseca K
Can Liver J. 2022; 3(4):323-333.
PMID: 35990510
PMC: 9202741.
DOI: 10.3138/canlivj-2019-0031.
The impact of the COVID-19 pandemic on hepatitis B virus vaccination and transmission among men who have sex with men: A mathematical modelling study.
Xiridou M, Adam P, Meiberg A, Visser M, Matser A, de Wit J
Vaccine. 2022; 40(33):4889-4896.
PMID: 35810058
PMC: 9250904.
DOI: 10.1016/j.vaccine.2022.06.075.
Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19.
Sagnelli C, Sica A, Creta M, Borsetti A, Ciccozzi M, Sagnelli E
Pathogens. 2022; 11(5).
PMID: 35631088
PMC: 9144674.
DOI: 10.3390/pathogens11050567.